Celcuity, Inc. (CELC)
93.24
-1.84
(-1.94%)
USD |
NASDAQ |
Aug 27, 16:00
92.61
-0.63
(-0.68%)
Pre-Market: 08:03
Celcuity Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 92.60 |
| June 26, 2026 | 90.28 |
| June 25, 2026 | 86.65 |
| June 24, 2026 | 87.06 |
| June 23, 2026 | 81.48 |
| June 22, 2026 | 81.23 |
| June 18, 2026 | 79.27 |
| June 17, 2026 | 79.53 |
| June 16, 2026 | 78.87 |
| June 15, 2026 | 79.70 |
| June 12, 2026 | 79.98 |
| June 11, 2026 | 80.83 |
| June 10, 2026 | 79.70 |
| June 09, 2026 | 83.63 |
| June 08, 2026 | 78.97 |
| June 05, 2026 | 79.74 |
| June 04, 2026 | 83.53 |
| June 03, 2026 | 80.35 |
| June 02, 2026 | 82.58 |
| June 01, 2026 | 111.07 |
| May 29, 2026 | 120.03 |
| May 28, 2026 | 118.25 |
| May 27, 2026 | 121.01 |
| May 26, 2026 | 121.27 |
| May 22, 2026 | 124.86 |
| Date | Value |
|---|---|
| May 21, 2026 | 128.74 |
| May 20, 2026 | 126.76 |
| May 19, 2026 | 118.29 |
| May 18, 2026 | 119.39 |
| May 15, 2026 | 124.36 |
| May 14, 2026 | 121.69 |
| May 13, 2026 | 112.43 |
| May 12, 2026 | 112.62 |
| May 11, 2026 | 113.49 |
| May 08, 2026 | 118.38 |
| May 07, 2026 | 118.07 |
| May 06, 2026 | 125.95 |
| May 05, 2026 | 127.98 |
| May 04, 2026 | 130.96 |
| May 01, 2026 | 113.50 |
| April 30, 2026 | 109.61 |
| April 29, 2026 | 107.49 |
| April 28, 2026 | 108.46 |
| April 27, 2026 | 113.52 |
| April 24, 2026 | 109.32 |
| April 23, 2026 | 102.58 |
| April 22, 2026 | 110.58 |
| April 21, 2026 | 113.88 |
| April 20, 2026 | 108.47 |
| April 17, 2026 | 110.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cogent Biosciences, Inc. | 13.61 |
| Replimune Group, Inc. | 12.40 |
| Erasca, Inc. | 16.83 |
| Apogee Therapeutics, Inc. | 8.512 |
| Arrowhead Pharmaceuticals, Inc. | 26.86 |
Price to Book Value Related Metrics
| PEG Ratio | -0.8771 |
| Price | 93.24 |
| Earnings Yield | -4.61% |
| Market Cap | 4.562B |
| PEGY Ratio | -0.8771 |